Clindamycin Palmitate Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Clindamycin Palmitate Hydrochloride Injection (injection) from Amneal Pharmaceuticals with status To Be Discontinued. The shortage was first posted on 03/26/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Amneal Pharmaceuticals
- Package NDC
- 53746-468-19
- Dosage Form
- Injection
- Presentation
- Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)
- Initial Posting
- 03/26/2026
- Revised Date